Navigation Links
Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms
Date:6/9/2009

Cardiatis SA, today announced that its Multilayer Aneurysm Repair System (MARS) has received CE Mark approval for treating patients with peripheral aneurysms. Product rollout is underway.

Brussels, Belgium (PRWEB) June 9, 2009 -- Cardiatis, SA announced today that it has received CE Mark approval for the commercial sale of its Multilayer Aneurysm Repair System.

The Multilayer Aneurysm Repair System (MARS) is based on non-invasive paradigm shifting technology that treats aneurysms, regardless of their location, endovasculary through hemodynamic flow modulation and parent artery repair techniques. The received CE Mark is for the peripheral indication and clinical development is underway for cerebral and thoraco-abdominal aortic aneurysm indications.

Due to novelty of the technology, Cardiatis has initiated limited rollout of the product to select interventional centers where physician training is underway.

"We are very pleased to provide physicians and patients with Cardiatis breakthrough Multilayer Aneurysm Repair System", said Noureddine Frid, Cardiatis president and chief executive officer. "Physicians will now have access to a new minimally-invasive technology that will allow them to treat peripheral aneurysms endovasculary while preserving precious collateral circulation."

The Multilayer Aneurysm Repair System (MARS) has proven to be highly deliverable and is effective in excluding aneurysms from circulation while preserving collaterals. It also offers an excellent safety profile, which is important to both physicians and patients.

More than 95% of peripheral artery aneurysms occur in males, and the average age of patients at presentation is 65 years. Atherosclerosis appears to be the etiology in more than 90% of cases. Popliteal artery aneurysms are the most common peripheral artery aneurysms accounting for up to 85% of total aneurysms in the periphery.

About Cardiatis

Cardiatis, an innovative medical technology company located in Belgium, is focused on developing and commercializing its patented Multilayer technology platform, a next generation technology for endovascular aneurysm repair. Additional information can be found on Cardiatis web site at www.cardiatis.com.

###

Read the full story at http://www.prweb.com/releases/Endovascular/Aneurysm/prweb2507714.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Too Few Screened for Abdominal Aneurysm, Study Says
2. NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System
3. Less Invasive Interventional Treatment Can Be Recommended as First-Line Treatment for Silent Killer, Abdominal Aortic Aneurysm
4. Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms
5. Aneurysms in 2nd Generation May Not Come Early
6. Routine testing after aneurysm coiling carries low risk
7. Brain Aneurysm Rupture Risk Tied to Location, Size
8. The Brain Aneurysm Foundation Announces 2008 Research Grant Recipients
9. NYC first: Complex aneurysm treated using new fenestrated endograft stent
10. Carnegie Mellon researchers improve assessments of aortic aneurysms
11. Women, Mexican-Americans at higher risk of ruptured brain aneurysm
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms
(Date:4/26/2017)... ... April 26, 2017 , ... Bioclinica® ... sponsors and CROs to speed clinical development, has released the industry’s only ... Bioclinica AGILE RTSM provides seamless clinical supply forecasting and management together ...
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
(Date:4/25/2017)... ... 2017 , ... As pharmaceutical companies are held to increasingly ... innovation in drug formulation and manufacturing. CoreRx offers its clients more than ... support of their development and manufacturing goals. , The company was created ...
(Date:4/25/2017)... Scotch Plains, NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD ... with the treatment of acute or chronic problems, I focus on preventative care with all ... patient. If you have any questions, always feel free to contact my office and my ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: